57894-0514 RYBREVANT FASPRO

Product NDC:

57894-0514

Brand Name:

RYBREVANT FASPRO

Generic Name:

AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)

Dosage Form Name:

INJECTION

Administration Route:

Subcutaneous

Substances:

Name: AMIVANTAMAB

Strength: 2240.0

Unit: mg/14mL

Name: HYALURONIDASE (HUMAN RECOMBINANT)

Strength: 28000.0

Unit: mg/14mL

Packages:

Code: 57894-0514-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (57894-514-01) / 14 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Dec. 17, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Bispecific Antibody

Minor Class:

EGFR, MET

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox